Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

6.790 -0.280 (-3.96%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2023

Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 08, 2023

We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday!

Via InvestorPlace

RingCentral, Alteryx, International Flavors & Fragrances And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 08, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

The Latest Analyst Ratings for Maravai LifeSciences ↗

May 09, 2023

Via Benzinga

Maravai LifeSciences (MRVI) Q2 2023 Earnings Call Transcript ↗

August 08, 2023

MRVI earnings call for the period ending June 30, 2023.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 07, 2023

Via Benzinga

Maravai LifeSciences Reports Second Quarter 2023 Financial Results

August 07, 2023

Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Tuesday ↗

August 01, 2023

On Tuesday, 46 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition

July 27, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023

July 24, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Maravai LifeSciences Announces Appointment of New Director to the Board

July 20, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Congressman Scott Peters Tours Maravai’s RNA manufacturing facility

June 06, 2023

Congressman Peters (D-CA-50) tours Wateridge manufacturing site in San Diego and celebrates Maravai’s impact in COVID vaccine production

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion

May 24, 2023

From TriLink BioTechnologies

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023 ↗

May 23, 2023

Via Benzinga

Maravai LifeSciences Shares Fall After Rejecting Potential Takeover By Private Equity ↗

May 16, 2023

Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) reportedly attracted takeover interest from Thomas H. Lee Partners with a non-binding offer, though the offer price could not be learned.

Via Benzinga

Analyst Says Maravai LifeSciences Not Immune From Macro Headwinds As Guidance Lags Consensus ↗

May 09, 2023

Maravai LifeSciences Holdings Inc's (NASDAQ: MRVI)

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023 ↗

May 09, 2023

Via Benzinga

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 09, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

Via Benzinga

TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog

May 09, 2023

Newest cap analog product improves mRNA potency with greater protein expression, offers time and cost savings, and streamlines manufacturing to drive critical therapeutic and vaccine development

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

PayPal, 3D Systems, Lucid Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 09, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Ohmyhome Limited (NASDAQ: OMH) shares dipped 48% to $13.52 in pre-market...

Via Benzinga

Maravai LifeSciences (MRVI) Q1 2023 Earnings Call Transcript ↗

May 09, 2023

MRVI earnings call for the period ending March 31, 2023.

Via The Motley Fool

Maravai LifeSciences Reports First Quarter 2023 Financial Results

May 08, 2023

Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023

April 17, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report

March 28, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

5 Value Stocks In The Healthcare Sector ↗

March 27, 2023

Via Benzinga

2 Top Biotech Stocks to Buy In March and Hold Forever ↗

March 13, 2023

Their price is right, and their future is bright.

Via The Motley Fool

Maravai LifeSciences Announces March 2023 Investor Conference Schedule

March 08, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.